P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES

por Yusuf, I., Guimond, D., Naiman, Z., Schiff, T., Clemons, B., Paulson, B., Hou, K., Taylor Meadows, K., Rose, M., Carter, L.
Publicado 2022